During the past decade, Shenzhen People's Hospital conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 4 clinical trials were completed, i.e. on average, 3.4% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 3 clinical trials were completed. i.e. 4.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shenzhen People's Hospital" #1 sponsor was "Shenzhen People's Hospital" with 25 trials, followed by "FibroGen" with 5 trials sponsored, "Shenzhen Second People's Hospital" with 5 trials sponsored, "Sun Yat-sen University" with 5 trials sponsored and "Beijing Chao Yang Hospital" with 5 trials sponsored. Other sponsors include 86 different institutions and companies that sponsored additional 71 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shenzhen People's Hospital" #1 collaborator was "Shenzhen People's Hospital" with 15 trials as a collaborator, "Dongguan People's Hospital" with 3 trials as a collaborator, "Sun Yat-sen University" with 3 trials as a collaborator, "Fifth Affiliated Hospital, Sun Yat-Sen University" with 2 trials as a collaborator and "Guangdong Provincial People's Hospital" with 2 trials as a collaborator. Other collaborators include 118 different institutions and companies that were collaborators in the rest 119 trials.

According to Clinical.Site data, the most researched conditions in "Shenzhen People's Hospital" are "Coronary Artery Disease" (4 trials), "Gastric Cancer" (4 trials), "Pulmonary Embolism" (4 trials), "Acute Coronary Syndrome" (3 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Shenzhen People's Hospital" in a lesser frequency.

Most popular intervention types in "Shenzhen People's Hospital" are "Drug" (93 trials), "Procedure" (20 trials), "Biological" (12 trials), "Other" (8 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Capecitabine" (4 trials), "FG-4592" (4 trials), "Apatinib Mesylate Tablets" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Shenzhen People's Hospital" are 127 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are 62 active trials in "Shenzhen People's Hospital". 7 are not yet recruiting, 38 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 32 completed trials in Shenzhen People's Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shenzhen People's Hospital, 8 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 25 trials that are defined as “Not Applicable".